Skip to main content

Advances in Oncology Extend Lives, but Lead to New Safety Considerations for Sponsors and Investigators

From cardiovascular adverse events to complex dosing regimens, oncology trials present unique safety-related considerations. Left unaddressed, they could undermine a trial or put patient safety at risk. In this paper, we discuss some of those issues and how sponsors can best address them.